Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cancers|June 22, 2023
Direct-Acting Oral Anticoagulant Therapy in Cancer Patients-A ReviewTomasz Górnicki, Kacper Bułdyś, Dorota Zielińska, et al.Journal of Clinical Medicine|October 27, 2022
The Quality of Life of Patients with Surgically Treated Colorectal Cancer: A Narrative ReviewFilip Świątkowski, Tomasz Górnicki, Kacper Bułdyś, et al.Cancer Management and Research|October 2, 2024
The Influence of Sociodemographic Factors and Clinical Aspects on the Quality of Life of Surgically Treated Patients with Colorectal CancerFilip Świątkowski, Jakub Lambrinow, Tomasz Górnicki, et al.International Journal of Molecular Sciences|January 11, 2022
The Impact of Iron Chelators on the Biology of Cancer Stem CellsJulia Szymonik, Kamila Wala, Tomasz Górnicki, et al.Cancer Medicine|July 20, 2024
New insights into the role of tetraspanin 6, 7, and 8 in physiology and pathologyMonika Mrozowska, Tomasz Górnicki, Mateusz Olbromski, et al.International Journal of Molecular Sciences|September 23, 2022
Role of RBMS3 Novel Potential Regulator of the EMT Phenomenon in Physiological and Pathological ProcessesTomasz Górnicki, Jakub Lambrinow, Monika Mrozowska, et al.Translational Oncology|November 12, 2024
Starting points for the development of new targeted therapies for glioblastoma multiformeAgnieszka Rusak, Benita Wiatrak, Klaudia Krawczyńska, et al.Healthcare (Basel, Switzerland)|June 28, 2023
What Do We Know about Nociplastic Pain?Kacper Bułdyś, Tomasz Górnicki, Dariusz Kałka, et al.Research Square|October 14, 2024
Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastomaAgnieszka Rusak, Marlena Gąsior-Głogowska, Azzurra Sargenti, et al.Pharmacological Reports : PR|November 28, 2024
Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastomaAgnieszka Rusak, Marlena Gąsior-Głogowska, Azzurra Sargenti, et al.Pageof 2